tosufloxacin has been researched along with Pulmonary Consumption in 1 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujishima, N | 1 |
Komiya, K | 1 |
Matsunaga, N | 1 |
Usagawa, Y | 1 |
Yamasue, M | 1 |
Hashinaga, K | 1 |
Umeki, K | 1 |
Nureki, SI | 1 |
Ando, M | 1 |
Matsunaga, T | 1 |
Kadota, JI | 1 |
1 other study available for tosufloxacin and Pulmonary Consumption
Article | Year |
---|---|
A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluoroquinolones; Humans; Male; Mycobacterium tuberculos | 2019 |